Voiceitt for People With Impairments in Speech
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13+
SponsorUniversity of Pittsburgh
About this trial
The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to conditions such as cerebral palsy (CP), stroke, Amyotrophic Lateral Sclerosis (ALS), or Parkinson's disease.
Eligibility criteria
Qualifiers
Age 13 or older
moderately severe speech dysarthria due to conditions such as CP, stroke, ALS or Parkinson's Disease, etc.
Ability to understand and follow instructions for using the Voiceitt app.
Disqualifiers
Severe cognitive impairments that prevent the understanding of the Voiceitt app and required training.
Patients who have additional speech impairments other than dysarthria, such as significant aphasia or verbal apraxia.
Severe physical impairments that prevent interaction with the app.
Non-English speakers.
Trial design
Treatments tested in this trial
- Voiceitt
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Pittsburgh
Lead sponsor
Duquesne University
Collaborator
Source ClinicalTrials.gov